Science & Technology

STTR Phase II: Development of a Antibiotic Releasing Intramedullary Nail for Treatment of Fracture Related Infections

National Science Foundation

Opportunity #: 2332648

Award Ceiling

$999K

Award Floor

$999K

Close Date

Jun 30, 2026

107 days left

Total Funding

$999K

Expected Awards

Posted Date

Jul 15, 2024

Cost Sharing Required

Grants.gov ID

sbir-2332648

Description

STTR Phase Phase II award: "STTR Phase II: Development of a Antibiotic Releasing Intramedullary Nail for Treatment of Fracture Related Infections" awarded to Reselute, Inc. in DURHAM, North Carolina. Funded by National Science Foundation. Award amount: $998,921. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.

Eligible Applicants

Small businesses, Women-owned businesses

Apply on Grants.gov

Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.

View on Grants.gov

Disclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.